| Pathology of congenital Zika syndrome in Brazil: a case series RB Martines, J Bhatnagar, AM de Oliveira Ramos, HPF Davi, ... The Lancet 388 (10047), 898-904, 2016 | 401 | 2016 |
| Vital signs: update on Zika virus–associated birth defects and evaluation of all US infants with congenital Zika virus exposure—US Zika Pregnancy Registry, 2016 MR Reynolds MMWR. Morbidity and mortality weekly report 66, 2017 | 332 | 2017 |
| Zika virus RNA replication and persistence in brain and placental tissue J Bhatnagar, DB Rabeneck, RB Martines, S Reagan-Steiner, Y Ermias, ... Emerging infectious diseases 23 (3), 405, 2017 | 259 | 2017 |
| Clinical pharmacology of polyethylene glycol-L-asparaginase. DH Ho, NS Brown, A Yen, R Holmes, M Keating, A Abuchowski, ... Drug metabolism and disposition 14 (3), 349-352, 1986 | 182 | 1986 |
| Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia HM Kantarjian, SM O’Brien, M Keating, M Beran, E Estey, S Giralt, ... Leukemia 11 (10), 1617-1620, 1997 | 125 | 1997 |
| The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia CA Koller, HM Kantarjian, D Thomas, S O’Brien, MB Rios, S Kornblau, ... Leukemia 11 (12), 2039-2044, 1997 | 111 | 1997 |
| Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia E Estey, P Thall, H Kantarjian, S Pierce, S Kornblau, M Keating Leukemia 11 (10), 1661-1664, 1997 | 111 | 1997 |
| Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases. L Fayad, H Kantarjian, S O’Brien, D Seong, M Albitar, M Keating, ... Leukemia (08876924) 11 (5), 1997 | 86 | 1997 |
| Aid, diplomacy and facts on the ground: The case of Palestine M Keating, A Le More, R Lowe Chatham House, 2005 | 80 | 2005 |
| Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine F Di Raimondo, R Giustolisi, S Lerner, E Cacciola, S O’Brien, H Kantarjian, ... Annals of Oncology 12 (5), 621-625, 2001 | 73 | 2001 |
| Combined fludarabine, cyclophosphamide, and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukemia. W Wierda, S O'Brien, M Albitar, S Lerner, W Plunkett, F Giles, M Andreeff, ... Blood 98 (11), 771A-771A, 2001 | 72 | 2001 |
| Single agent Rituxan in early stage chronic lymphocytic leukemia (CLL). DA Thomas, S O'Brien, FJ Giles, J Cortes, S Faderl, H Kantarjian, ... Blood 98 (11), 364A-364A, 2001 | 67 | 2001 |
| GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia J Cortes, H Kantarjian, S O’brien, R Kurzrock, M Keating, M Talpaz Leukemia 12 (6), 860-864, 1998 | 53 | 1998 |
| Evaluation of placental and fetal tissue specimens for zika virus infection—50 states and District of Columbia, January–December, 2016 S Reagan-Steiner MMWR. Morbidity and mortality weekly report 66, 2017 | 48 | 2017 |
| Contemporary food imagery: food porn and other visual trends N Taylor, M Keating Communication Research and Practice 4 (3), 307-323, 2018 | 47 | 2018 |
| Outbreak of tattoo-associated nontuberculous mycobacterial skin infections I Griffin, A Schmitz, C Oliver, S Pritchard, G Zhang, E Rico, E Davenport, ... Clinical Infectious Diseases 69 (6), 949-955, 2019 | 44 | 2019 |
| Update of results of the combination of fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL). GG Manero, S O'Brien, J Cortes, S Faderl, F Giles, M Albitar, S Lerner, ... Blood 98 (11), 633A-633A, 2001 | 42 | 2001 |
| Clinical characteristics, histopathology, and tissue immunolocalization of chikungunya virus antigen in fatal cases TM Sharp, MK Keating, WJ Shieh, J Bhatnagar, BC Bollweg, R Levine, ... Clinical Infectious Diseases 73 (2), e345-e354, 2021 | 37 | 2021 |
| High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML … EH Estey, HM Kantarjian, S O'brien, S Kornblau, M Andreeff, M Beran, ... Cytokines and Molecular Therapy 1 (1), 21-28, 1995 | 37 | 1995 |
| Compound 506 has activity in mature lymphoid leukemia. S O'brien, D Thomas, H Kantarjian, E Freireich, C Koller, J Cortes, F Giles, ... Blood 92 (10), 490A-491A, 1998 | 32 | 1998 |
